Evaluation of a sustained-release theophylline tablet in Young asthmatics

Scott A. Swigart, Roger H. Kobayashi, Jeffrey N. Baldwin

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


A sustained-release theophylline (SRT) tablet was evaluated in 15 children with moderately severe asthma between the ages of 3 and 5 years (4.2 ± 0.83 years). They received a mean daily dose of 20.4 mg/kg given q12h for 3 or more weeks with daily symptom scores and twice daily peak flow rates (PFR) measured. Serum theophylline levels (STL) were then obtained at 0, 1, 2, 4, 6, 8, 10, and 12 hr (eight children had 24-hr samples obtained), along with PFRs every 3 hr. The mean peak STL (x ± SD) was 16.6 ± 4.4 and the trough was 5.9 ± 2.8, with a peak-trough difference of 10.6 ± 3.9. The average time to peak level was 3.9 hr. The mean ±SD clearance was 1.42 ± 0.63 ml/kg per min and the apparent T1/2 was 5.11 ± 1.34 hr. The average weekly morning PFR for the 3-week period ranged from 116.8 ± 41.2 to 127.4 ± 37.4 L/min, and the evening PFT ranged from 126.5 ± 38.4 to 137.0 ± 40.9 L/min. In conclusion, the SRT tablet is effective in treating many young asthmatics on a 12-hr dosage schedule. For some children who experience excessive peak-trough differences, an 8-hr dosage schedule may be indicated.

Original languageEnglish (US)
Pages (from-to)195-202
Number of pages8
JournalJournal of Asthma
Issue number4
StatePublished - 1985
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Evaluation of a sustained-release theophylline tablet in Young asthmatics'. Together they form a unique fingerprint.

Cite this